{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:23:31Z","timestamp":1772252611958,"version":"3.50.1"},"reference-count":32,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Background: The use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) is controversial for treating COVID-19 patients. We aimed to estimate pooled risks of mortality, disease severity, and hospitalization associated with ACEI\/ARB use and stratify them by country and country clusters. Methods: We conducted a search in various databases through 4 July 2020 and then applied random-effects models to estimate pooled risks (ORp) across stratifications by country cluster. Clusters were chosen to reflect outbreak times (China followed by Korea\/Italy, others subsequently) and mobility restrictions (China and Denmark\/France\/Spain with stricter lockdowns than the UK\/US). Results: Overall analysis showed no increase in mortality; however, a statistical increase in mortality was seen in the US\/UK cluster with ORp = 1.28 [95% CI = 1.04; 1.56] and a decrease in China with ORp = 0.65 [95% CI = 0.43; 0.96] and France with OR = 0.31 [95% CI = 0.14; 0.69]. Severity and hospitalization were not statistically significant in the analysis; however, several associations were seen in specific countries but not in country clusters. Conclusion: The country-cluster meta-analysis provided a reasonable explanation for COVID-19 mortality among ACEI\/ARB users. The analysis did not explain differences in severity and suggested the involvement of other factors. Hospitalization findings among ACEI\/ARB users may be considered informative as they may have been subjected to clinical decisions and hospital-bed availability.<\/jats:p>","DOI":"10.3390\/healthcare9020127","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T09:03:45Z","timestamp":1611824625000},"page":"127","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mortality, Severity, and Hospital Admission among COVID-19 Patients with ACEI\/ARB Use: A Meta-Analysis Stratifying Countries Based on Response to the First Wave of the Pandemic"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2091-1376","authenticated-orcid":false,"given":"Ahmad A.","family":"Alamer","sequence":"first","affiliation":[{"name":"Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, 1295 N Martin Ave, Tucson, AZ 85721, USA"},{"name":"Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj 11942, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3727-7543","authenticated-orcid":false,"given":"Abdulaziz S.","family":"Almulhim","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Clinical Pharmacy, King Faisal University, Al-Ahasa 31982, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed A.","family":"Alrashed","sequence":"additional","affiliation":[{"name":"Pharmaceutical Service Department, Main Hospital, King Fahad Medical City, Riyadh 11564, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo","family":"Abraham","sequence":"additional","affiliation":[{"name":"Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, 1295 N Martin Ave, Tucson, AZ 85721, USA"},{"name":"Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41586-020-2405-7","article-title":"Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe","volume":"584","author":"Flaxman","year":"2020","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1016\/S0140-6736(20)31035-7","article-title":"The invisible pandemic","volume":"395","author":"Giesecke","year":"2020","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S0140-6736(20)31673-1","article-title":"COVID-19-a very visible pandemic","volume":"396","author":"Ramachandran","year":"2020","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"100464","DOI":"10.1016\/j.eclinm.2020.100464","article-title":"A country level analysis measuring the impact of government actions, country preparedness and socioeconomic factors on COVID-19 mortality and related health outcomes","volume":"25","author":"Chaudhry","year":"2020","journal-title":"EClinicalMedicine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1164\/rccm.202002-0445OC","article-title":"COVID-19 with Different Severities: A Multicenter Study of Clinical Features","volume":"201","author":"Feng","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_7","first-page":"1","article-title":"Outcomes in Patients with COVID-19 Infection Taking ACEI\/ARB","volume":"22","author":"White","year":"2020","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"104927","DOI":"10.1016\/j.phrs.2020.104927","article-title":"ACEI\/ARB use and risk of infection or severity or mortality of COVID-19: A systematic review and meta-analysis","volume":"158","author":"Zhang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kansagara, D., Mackey, K., and Vela, K. (2020). Update Alert: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann. Intern. Med.","DOI":"10.7326\/L20-0887"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7326\/M20-1515","article-title":"Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults","volume":"173","author":"Mackey","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-014-0579-0","article-title":"PICO, PICOS and SPIDER: A comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews","volume":"14","author":"Methley","year":"2014","journal-title":"BMC Heal. Serv. Res."},{"key":"ref_12","unstructured":"China NHCotPsRo (2020). Diagnosis and Treatment Protocol for COVID-19 Patients."},{"key":"ref_13","unstructured":"World Health Organization (2020). Clinical Management of COVID-19, WHO."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_15","unstructured":"Douglas, G. (1991). Practical Statistics for Medical Research. Statistics in Medicine, Altman, Chapman and Hall."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Deeks, J.J., Higgins, J.P., and Altman, D.G. (2019). Analysing data and undertaking meta-analyses. Cochrane Handbook for Systematic Reviews of Interventions, Cochrane Statistical Methods Group.","DOI":"10.1002\/9781119536604.ch10"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: A practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"\u00c9vid. Based Ment. Health"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res. Synth. Methods"},{"key":"ref_19","unstructured":"Wells, G. (2020, August 01). The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analysis. Available online: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"ref_21","unstructured":"(2020, September 15). Worldodometer Coronavirus. Available online: https:\/\/www.worldometers.info\/coronavirus\/country\/uk\/."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ejhf.1924","article-title":"ACE-inhibitors and Angiotensin-2 Receptor Blockers are not associated with severe SARS-COVID19 infection in a multi-site UK acute Hospital Trust","volume":"22","author":"Bean","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_23","unstructured":"(2020, August 01). Governor Cuomo Issues Guidance on Essential Services Under The \u2019New York State on PAUSE\u2019 Executive Order, Available online: https:\/\/www.governor.ny.gov\/news\/governor-cuomo-issues-guidance-essential-services-under-new-york-state-pause-executive-order."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1126\/science.aba9757","article-title":"The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak","volume":"368","author":"Chinazzi","year":"2020","journal-title":"Science"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e1753464","DOI":"10.1080\/23288604.2020.1753464","article-title":"National Response to COVID-19 in the Republic of Korea and Lessons Learned for Other Countries","volume":"6","author":"Oh","year":"2020","journal-title":"Heal. Syst. Reform"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1515\/cclm-2020-0727","article-title":"Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?","volume":"58","author":"Lippi","year":"2020","journal-title":"Clin. Chem. Lab Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1136\/heartjnl-2020-317393","article-title":"Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: Cohort study including 8.3 million people","volume":"106","author":"Young","year":"2020","journal-title":"Heart"},{"key":"ref_28","first-page":"E64","article-title":"The Spanish Influenza Pandemic: A lesson from history 100 years after 1918","volume":"60","author":"Martini","year":"2019","journal-title":"J. Prev. Med. Hyg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.cell.2020.06.040","article-title":"Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear","volume":"182","author":"Grubaugh","year":"2020","journal-title":"Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.amepre.2010.07.014","article-title":"Vaccination deep into a pandemic wave potential mechanisms for a \u201cthird wave\u201d and the impact of vaccination","volume":"39","author":"Lee","year":"2010","journal-title":"Am. J. Prev. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e01083-20","DOI":"10.1128\/JVI.01083-20","article-title":"COVID-19 Vaccines: \u201cWarp Speed\u201d Needs Mind Melds, Not Warped Minds","volume":"94","author":"Moore","year":"2020","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/9\/2\/127\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:16:43Z","timestamp":1760159803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/9\/2\/127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["healthcare9020127"],"URL":"https:\/\/doi.org\/10.3390\/healthcare9020127","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-75674\/v1","asserted-by":"object"}]},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,28]]}}}